Skip to main content
OpenTrials
Completed

NCT Number: NCT02473666

Patient Blood Management - Use and Outcome

Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich

Zurich, 8091, Switzerland

About this study

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Only case records, all discharged patients of the University Hospital of Zürich

Exclusion criteria

  • Not discharged from our Hospital.

Treatment and study plan

Primary outcomes

  1. Percentage of transfusions per participant

    Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

    Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions

Secondary outcomes

  1. Percentage of transfusion of any blood product per participant

    Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

    Count of any blood products per case, QM Data

  2. Cost of any blood product per participant

    Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

    costs per case

  3. Survey of Patient Blood Management System

    Time frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

    clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Acronym: PBM-USZ

Important dates

Study start
2012
Primary completion
2019
Study completion
2019
First posted
Jun 16, 2015
Registry last updated
Nov 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.